Mahendra G. Shah

Mahendra is a highly successful pharmaceutical entrepreneur and executive who has been at Vivo Capital since March 2010. He is also the founder and executive chairman of Semnur Pharmaceuticals. Mahendra currently serves as Chairman of the Board of Essentialis Therapeutics, Board Member of Biotie Therapies (NASDAQ: BITI), and a Member of the Board of Trustees of St. John’s University. He is also a Board Member and Charter Member of EPPIC and a Charter Member of TIE.

From September 2005 to December 2009, he was the Founder, Chairman and CEO of NextWave Pharmaceuticals, a pediatric-focused specialty pharmaceutical company, which was sold to Pfizer for a total of $700 million in upfront and milestone payments. From 1993 to May 2003, he was the Chairman and CEO of First Horizon Pharmaceuticals, a publicly traded specialty pharmaceutical company, where he raised over $200 million and built a highly profitable company before it was sold to Shionogi Pharmaceuticals for $1.4 billion. From 1991 to October 1999, he was Vice President of E. J. Financial Enterprises, Inc., which manages a fund that invests in healthcare companies.